| Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness (NCT04324944) | VA Office of Research and Development | 2022-07-05 |
| Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (NCT05660070) | University of California, San Diego | 2022-07-01 |
| Exercise Target Brain Oscillations in Psychosis (NCT05338424) | University of Minnesota | 2022-07-01 |
| Luteolin for the Treatment of People With Schizophrenia (NCT05204407) | University of Maryland, Baltimore | 2022-06-13 |
| Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study (NCT05380583) | Mclean Hospital | 2022-05-19 |
| Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial (NCT05208190) | New York State Psychiatric Institute | 2022-03-17 |
| Academic-Community EPINET (AC-EPINET) (NCT04497857) | Indiana University | 2022-03-16 |
| Sodium Nitroprusside in Early Course Schizophrenia (NCT04986072) | Beth Israel Deaconess Medical Center | 2022-03-14 |
| CLOZAPINE Response in Biotype-1 (NCT04580134) | University of Texas Southwestern Medical Center | 2022-03-01 |
| Synbiotic Compound to Reduce Symptoms of Schizophrenia (NCT04226898) | Sheppard Pratt Health System | 2022-02-21 |
| State Representation in Early Psychosis (NCT05273164) | University of Minnesota | 2021-12-01 |
| Mobile Self-Tracking of Mental Health (NCT05023252) | VA Office of Research and Development | 2021-10-18 |
| Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings (NCT05030272) | Wake Forest University Health Sciences | 2021-09-21 |
| Memantine Augmentation of Targeted Cognitive Training in Schizophrenia (NCT04857983) | University of California, San Diego | 2021-07-06 |
| eMove - Dance/Movement Therapy Study (NCT05712928) | Drexel University | 2021-06-29 |
| Feasibility of a Novel Process-based Treatment for Patients With Psychosis (NCT04874974) | Max-Planck-Institute of Psychiatry | 2021-05-10 |
| The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis (NCT04916626) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2021-05-06 |
| M1 Schizophrenia PET Study (NCT05105542) | Yale University | 2021-04-20 |
| Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders (NCT04783285) | CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas | 2021-03-29 |
| Horyzons: Implementation in Clinical Practice (NCT04673851) | University of North Carolina, Chapel Hill | 2021-01-19 |
| Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy (NCT05140135) | University of Pennsylvania | 2021-01-11 |
| Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing (NCT04554121) | Columbia University | 2020-12-14 |
| Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders (NCT04418011) | Centre for Addiction and Mental Health | 2020-11-30 |
| Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia (NCT04414930) | University of California, San Diego | 2020-11-09 |
| Families With Substance Use and Psychosis: A Pilot Study (NCT04284813) | Mclean Hospital | 2020-09-24 |
| ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention (NCT04298450) | Centre for Addiction and Mental Health | 2020-09-21 |
| Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis (NCT05784948) | Chonbuk National University Hospital | 2020-04-08 |
| Survey on Pre-ECT Evaluation and ECT Application (NCT04335916) | Klinički Bolnički Centar Zagreb | 2020-04-01 |
| BXCL501 for Agitation in Schizophrenia (NCT03708315) | Yale University | 2020-03-09 |
| Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia (NCT04268303) | BioXcel Therapeutics Inc | 2020-01-24 |
| The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia (NCT04013555) | University of Maryland, Baltimore | 2020-01-20 |
| Evaluation of mHealth for Serious Mental Illness (NCT04068467) | University of Washington | 2020-01-06 |
| Early Psychosis Intervention - Spreading Evidence-based Treatment (NCT03919760) | Centre for Addiction and Mental Health | 2020-01-03 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial (NCT04173572) | University of North Carolina, Chapel Hill | 2019-12-20 |
| Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS) (NCT04144231) | Helsinki University Central Hospital | 2019-12-19 |
| Estradiol as add-on to Antipsychotics (NCT04093518) | Tangent Data | 2019-12-02 |
| Comparing Cognitive Remediation Approaches for Schizophrenia (NCT04123223) | Wesleyan University | 2019-11-01 |
| Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia (NCT04545294) | Tri-Service General Hospital (TSGH) | 2019-08-14 |
| Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness (NCT04011280) | University of California, San Diego | 2019-08-12 |
| Prebiotic Treatment in People With Schizophrenia - Pilot Study (NCT03617783) | University of Maryland, Baltimore | 2019-07-18 |
| Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2 (NCT03896438) | University of Minnesota | 2019-07-01 |
| Cognitive Remediation for Coordinated Specialty Care (NCT03930251) | New York State Psychiatric Institute | 2019-06-01 |
| Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) (NCT03873337) | Rutgers, The State University of New Jersey | 2019-04-22 |
| Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM) (NCT03829280) | The University of Texas Health Science Center at San Antonio | 2019-04-04 |
| Mobile CBT for Negative Symptoms (NCT03621774) | University of California, San Diego | 2019-03-27 |
| Improving Visual Attention in Schizophrenia (NCT03880227) | The University of Texas at Dallas | 2019-03-25 |
| Overcoming Psychomotor Slowing in Psychosis (OCoPS-P) (NCT03921450) | University of Bern | 2019-03-25 |
| Verbal Memory Training Using Virtual Reality in Schizophrenia (NCT04251195) | The Royal Ottawa Mental Health Centre | 2019-02-12 |
| Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. (NCT03510741) | Pakistan Institute of Living and Learning | 2019-01-01 |
| Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates (NCT03495024) | Corporal Michael J. Crescenz VA Medical Center | 2019-01-01 |
| A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients (NCT03751488) | Luye Pharma Group Ltd. | 2018-12-12 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life (NCT03757988) | University of North Carolina, Chapel Hill | 2018-12-06 |
| OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis (NCT03390491) | Center for Social Innovation, Massachusetts | 2018-11-01 |
| Motivation and Skills Support (MASS) (NCT03404219) | Boston University Charles River Campus | 2018-11-01 |
| Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia (NCT04038788) | Tri-Service General Hospital (TSGH) | 2018-10-24 |
| Improving Accessibility and Personalization of CR for Schizophrenia (NCT03576976) | New York State Psychiatric Institute | 2018-07-16 |
| Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder (NCT03526354) | University of Massachusetts, Worcester | 2018-06-19 |
| Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis (NCT03316664) | Psychiatric University Hospital, Zurich | 2018-06-01 |
| Remediation of Visual Perceptual Impairments in People With Schizophrenia (NCT03314129) | University of Rochester | 2018-06-01 |
| A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (NCT03568500) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-05-21 |
| Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia (NCT03860597) | University of California, San Diego | 2018-04-01 |
| Texting for Relapse Prevention (NCT02819349) | Center for Innovative Public Health Research | 2018-03-12 |
| Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis (NCT03409393) | Rigshospitalet, Denmark | 2018-01-22 |
| Stimulating the Brain to Improve Self-Awareness (NCT03370341) | The University of Texas at Dallas | 2017-12-01 |
| Theta Burst Stimulation for Schizophrenia (NCT03288779) | Duke University | 2017-10-24 |
| Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness (NCT03062267) | University of Washington | 2017-10-01 |
| Neural Biomarkers of Clozapine Response (NCT03076346) | University of Pittsburgh | 2017-09-01 |
| The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia (NCT03701100) | Tri-Service General Hospital (TSGH) | 2017-07-17 |
| Lifestyle Intervention for Young Adults With Serious Mental Illness (NCT02815813) | Dartmouth-Hitchcock Medical Center | 2017-07-03 |
| Virtual Reality Job Interview Training in Severe Mental Illness (NCT03049813) | University of Michigan | 2017-06-01 |
| Minnesota Community-Based Cognitive Training in Early Psychosis (NCT03079024) | University of Minnesota | 2017-05-19 |
| Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care. (NCT03240380) | Universitätsklinikum Hamburg-Eppendorf | 2017-05-01 |
| The Appeal and Impact of E-cigarettes in Smokers With SMI (NCT03050853) | Dartmouth-Hitchcock Medical Center | 2017-03-01 |
| Cognitive Behavioral Social Skills Training in Early Onset Psychosis (NCT03261557) | Hospital Clinic of Barcelona | 2017-02-22 |
| Sulforaphane to Reduce Symptoms of Schizophrenia (NCT02810964) | Sheppard Pratt Health System | 2017-02-22 |
| Sustainable Early Episode Clinic Study (SEEC) (NCT03571685) | Janssen Scientific Affairs, LLC | 2017-01-31 |
| Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program (NCT03005574) | Boston University Charles River Campus | 2017-01-27 |
| A Randomised Controlled Trial of Coenzyme Q10 in Patients With Schizophrenia and Schizoaffective Disorder (NCT03576911) | University of Dublin, Trinity College | 2016-11-01 |
| Clinical Trial of AVL-3288 in Schizophrenia Patients (NCT02978599) | New York State Psychiatric Institute | 2016-11-01 |
| Schizophrenia and the Gut Microbiome (NCT02921243) | University of Maryland, Baltimore | 2016-10-01 |
| Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia (NCT03061136) | Palo Alto Veterans Institute for Research | 2016-10-01 |
| MEtformin and Lorcaserin for WeighT Loss in Schizophrenia (NCT02796144) | University of North Carolina, Chapel Hill | 2016-09-01 |
| Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder (NCT02901587) | H. Lundbeck A/S | 2016-09-01 |
| Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) (NCT02782442) | University of Minnesota | 2016-09-01 |
| Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia (NCT03179696) | Eric Granholm | 2016-08-15 |
| Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder (NCT03043820) | Iris Sommer | 2016-08-01 |
| Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia (NCT02639702) | Centre for Addiction and Mental Health | 2016-08-01 |
| The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia (NCT03388554) | Tri-Service General Hospital (TSGH) | 2016-07-01 |
| The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial (NCT02453217) | Wai-Tong Chien | 2016-03-31 |
| Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers (NCT02386605) | VA Office of Research and Development | 2016-03-28 |
| Research Into Antipsychotic Discontinuation and Reduction Trial (NCT03559426) | University College, London | 2016-03-24 |
| Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study (NCT02642029) | Mclean Hospital | 2016-02-18 |
| A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia (NCT02476708) | Yale University | 2016-02-11 |
| Positive Emotions Program for Schizophrenia (PEPS) (NCT02593058) | Institut et Haute Ecole de la Santé la Source | 2016-02-01 |
| Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia (NCT02661347) | Northwell Health | 2016-02-01 |
| Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence (NCT02665611) | Assuta Hospital Systems | 2016-02-01 |
| Cannabidiol Treatment in Patients With Early Psychosis (NCT02504151) | Yale University | 2016-01-28 |
| Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics (NCT02573168) | St. Joseph's Healthcare Hamilton | 2016-01-01 |
| Video as a Tool to Improve Insight in Schizophrenia (NCT02664129) | University Hospital, Montpellier | 2015-12-08 |
| Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder (NCT03848234) | Tangent Data | 2015-12-04 |